Application of an endothelialized modular construct for islet transplantation in syngeneic and allogeneic immunosuppressed rat models

Tissue Engineering - Part A

Volumn 17, Issue 15-16, 2011, Pages 2005-2015

  Gupta, Rohini ^a   Sefton, Michael V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GLUCOSE; MODELS; RATS; TISSUE; TISSUE ENGINEERING;

BLOOD GLUCOSE LEVEL; DIABETIC RATS; ENGRAFTMENT; GRAFT FAILURE; ISLET TRANSPLANTATION; MODULAR APPROACH; RAT MODEL; SHORT TERM; SMOOTH MUSCLE CELLS; VASCULARIZATION; VASCULATURE;

ENDOTHELIAL CELLS;

RATTUS;

GREEN FLUORESCENT PROTEIN; INSULIN; TISSUE SCAFFOLD;

ALLOTRANSPLANTATION; ANIMAL; ANIMAL MODEL; ARTICLE; BLOOD; CATTLE; CHEMISTRY; DIET RESTRICTION; ENDOTHELIUM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IMMUNOSUPPRESSIVE TREATMENT; LEWIS RAT; MALE; METABOLISM; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; RAT; SPRAGUE DAWLEY RAT; TISSUE SURVIVAL; VASCULARIZATION;

ANIMALS; BLOOD GLUCOSE; CATTLE; ENDOTHELIUM; FASTING; GLUCOSE TOLERANCE TEST; GREEN FLUORESCENT PROTEINS; IMMUNOSUPPRESSION; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MODELS, ANIMAL; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; TISSUE SCAFFOLDS; TISSUE SURVIVAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 79960808429     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0542     Document Type: Article

References (47)

1. Merani, S., and Shapiro, A.M. Current status of pancreatic islet transplantation. Clin Sci (Lond) 110, 611, 2006.
2. Alejandro, R., Barton, F.B., Hering, B.J., and Wease, S. 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 86, 1783, 2008.
3. Fiorina, P., Shapiro, A.M.J., Ricordi, C., and Secchi, A. The clinical impact of islet transplantation. Am J Transplant 8, 1990, 2008.
4. Shapiro, A.M., Ricordi, C., Hering, B.J., Auchincloss, H., Lindblad, R., Robertson, R.P., et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355, 1318, 2006.
5. Balamurugan, A.N., Bottino, R., Giannoukakis, N., and Smetanka, C. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas 32, 231, 2006.
6. Barshes, N.R., Wyllie, S., and Goss, J.A. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 77, 587, 2005.
7. Kizilel, S., Scavone, A., Liu, X., Nothias, J.M., Ostrega, D., Witkowski, P., et al. Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion. Tissue Eng Part A 16, 2217, 2010.
8. Lin, C.C., and Anseth, K.S. Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells. Biomacromolecules 10, 2460, 2009.
9. Konstantinova, I., and Lammert, E. Microvascular development: learning from pancreatic islets. Bioessays 26, 1069, 2004.
10. Olsson, R., and Carlsson, P.O. The pancreatic islet endothelial cell: emerging roles in islet function and disease. Int J Biochem Cell Biol 38, 710, 2006.
11. Carlsson, P.O., Palm, F., Andersson, A., and Liss, P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50, 489, 2001.
12. Mattsson, G., Jansson, L., and Carlsson, P.O. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51, 1362, 2002.
13. Mattsson, G., Jansson, L., Nordin, A., and Carlsson, P.O. Impaired revascularization of transplanted mouse pancreatic islets is chronic and glucose-independent. Transplantation 75, 736, 2003.
14. Lai, Y., Schneider, D., Kidszun, A., Hauck-Schmalenberger, I., Breier, G., Brandhorst, D., et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 79, 1530, 2005.
15. Stagner, J., Mokshagundam, S., Wyler, K., Samols, E., Rilo, H., Stagner, M., et al. Beta-cell sparing in transplanted islets by vascular endothelial growth factor. Transplant Proc 36, 1178, 2004.
16. Stendahl, J.C., Wang, L.J., Chow, L.W., Kaufman, D.B., and Stupp, S.I. Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation 86, 478, 2008.
17. Zhang, N., Richter, A., Suriawinata, J., Harbaran, S., Altomonte, J., Cong, L., et al. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53, 963, 2004.
18. Koike, N., Fukumura, D., Gralla, O., Au, P., Schechner, J.S., and Jain, R.K. Creation of long-lasting blood vessels. Nature 428, 138, 2004.
19. Merx, M.W., Zernecke, A., Liehn, E.A., Schuh, A., Skobel, E., Butzbach, B., et al. Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Res Cardiol 100, 208, 2005.
20. Shepherd, B.R., Enis, D.R., Wang, F., Suarez, Y., Pober, J.S., and Schechner, J.S. Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endothelial cells. FASEB J 20, 1739, 2006.
21. Stevens, K.R., Kreutziger, K.L., Dupras, S.K., Korte, F.S., Regnier, M., Muskheli, V., et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA 106, 16568, 2009.
22. Lesman, A., Habib, M., Caspi, O., Gepstein, A., Arbel, G., Levenberg, S., et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A 16, 115, 2010.
23. McGuigan, A.P., and Sefton, M.V. Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci USA 103, 11461, 2006.
24. McGuigan, A.P., and Sefton, M.V. Design and fabrication of sub-mm-sized modules containing encapsulated cells for modular tissue engineering. Tissue Eng 13, 1069, 2007.
25. Leung, B.M., and Sefton, M.V. A modular tissue engineering construct containing smooth muscle cells and endothelial cells. Ann Biomed Eng 35, 2039, 2007.
26. Leung, B., and Sefton, M.V. A modular approach to cardiac tissue engineering. Tissue Eng Part A 16, 3207, 2010.
27. Gupta, R., van Rooijen, N., and Sefton, M.V. Fate of endothelialized modular constructs implanted in an omental pouch in nude rats. Tissue Eng Part A 15, 2875, 2009.
28. Chamberlain, M.D., Gupta, R., and Sefton, M.V. Chimeric vessel tissue engineering driven by endothelialized modules in immunosuppressed Sprague-Dawley rats. Tissue Eng Part A 17, 151, 2010.
29. Yoshimitsu, M., Higuchi, K., Ramsubir, S., Nonaka, T., Rasaiah, V.I., Siatskas, C., et al. Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/progenitor cells. Gene Ther 14, 256, 2007.
30. Yoshimitsu, M., Sato, T., Tao, K., Walia, J.S., Rasaiah, V.I., Sleep, G.T., et al. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc Natl Acad Sci USA 101, 16909, 2004.
31. Kin, T., Korbutt, G.S., and Rajotte, R.V. Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant 3, 281, 2003.
32. Ricordi, C., Gray, D.W., Hering, B.J., Kaufman, D.B., Warnock, G.L., Kneteman, N.M., et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 27, 185, 1990.
33. Lucasclerc, C., Massart, C., Campion, J.P., Launois, B., and Nicol, M. Long-term culture of human pancreatic-islets in an extracellular-matrix- morphological and metabolic effects. Mol Cell Endocrinol 94, 9, 1993.
34. Wang, R.N., and Rosenberg, L. Maintenance of beta-cell function and survival following islet isolation requires reestablishment of the islet-matrix relationship. J Endocrinol 163, 181, 1999.
35. Holmes, M.A., Clayton, H.A., Chadwick, D.R., Bell, P.R., London, N.J., and James, R.F. Functional studies of rat, porcine, and human pancreatic islets cultured in ten commercially available media. Transplantation 60, 854, 1995.
36. Vestweber, D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28, 223, 2008.
37. Wu, J.Q., and Sheibani, N. Modulation of VE-cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases. J Cell Biochem 90, 121, 2003.
38. Larsen, J.L., Bennett, R.G., Burkman, T., Ramirez, A.L., Yamamoto, S., Gulizia, J., et al. Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. Transplantation 82, 466, 2006.
39. Lopez-Talavera, J.C., Garcia-Ocana, A., Sipula, I., Takane, K.K., Cozar-Castellano, I., and Stewart, A.F. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology 145, 467, 2004.
40. Hiscox, A.M., Stone, A.L., Limesand, S., Hoying, J.B., and Williams, S.K. An islet-stabilizing implant constructed using a preformed vasculature. Tissue Eng Part A 14, 433, 2008.
41. Merani, S., Toso, C., Emamaullee, J., and Shapiro, A.M. Optimal implantation site for pancreatic islet transplantation. Br J Surg 95, 1449, 2008.
42. Brissova, M., Shostak, A., Shiota, M., Wiebe, P.O., Poffenberger, G., Kantz, J., et al. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55, 2974, 2006.
43. Nyqvist, D., Kohler, M., Wahlstedt, H., and Berggren, P.O. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes 54, 2287, 2005.
44. Linn, T., Schneider, K., Hammes, H.P., Preissner, K.T., Brandhorst, H., Morgenstern, E., et al. Angiogenic capacity of endothelial cells in islets of Langerhans. Faseb J 17, 881, 2003.
45. Brissova, M., Fowler, M., Wiebe, P., Shostak, A., Shiota, M., Radhika, A., et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 53, 1318, 2004.
46. Solari, M.G., Srinivasan, S., Boumaza, I., Unadkat, J., Harb, G., Garcia-Ocana, A., et al. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J Autoimmun 32, 116, 2009.
47. Fumimoto, Y., Matsuyama, A., Komoda, H., Okura, H., Lee, C.M., Nagao, A., et al. Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice. Tissue Eng Part C Methods 15, 437, 2009.